Mengdie Yuan

725 total citations · 1 hit paper
10 papers, 455 citations indexed

About

Mengdie Yuan is a scholar working on Statistics and Probability, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengdie Yuan has authored 10 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Statistics and Probability, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengdie Yuan's work include Statistical Methods and Inference (3 papers), Statistical Methods in Clinical Trials (3 papers) and Statistical Methods and Bayesian Inference (2 papers). Mengdie Yuan is often cited by papers focused on Statistical Methods and Inference (3 papers), Statistical Methods in Clinical Trials (3 papers) and Statistical Methods and Bayesian Inference (2 papers). Mengdie Yuan collaborates with scholars based in United States and China. Mengdie Yuan's co-authors include Steven J. Lemery, Lola A. Fashoyin‐Aje, Richard Pazdur, Marc R. Theoret, Martha Donoghue, Lisa Rodríguez, Pamela Gallagher, Leigh Marcus, Reena Philip and Julia A. Beaver and has published in prestigious journals such as Clinical Cancer Research, Statistics in Medicine and The Oncologist.

In The Last Decade

Mengdie Yuan

10 papers receiving 451 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

2021 330 citations Leigh Marcus, Lola A. Fashoyin‐Aje et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mengdie Yuan United States	5	308	146	131	78	76	10	455
Guoqiang Wang China	9	455 1.5×	227 1.6×	88 0.7×	101 1.3×	89 1.2×	24	561
Ashish Sangal United States	8	339 1.1×	208 1.4×	132 1.0×	76 1.0×	67 0.9×	19	464
Vito Longo Italy	12	284 0.9×	128 0.9×	94 0.7×	95 1.2×	127 1.7×	29	487
G. Pasquini Italy	10	306 1.0×	201 1.4×	166 1.3×	92 1.2×	210 2.8×	27	529
Robert Alter United States	10	264 0.9×	206 1.4×	88 0.7×	91 1.2×	132 1.7×	29	466
Zhen-Hai Lu China	15	462 1.5×	97 0.7×	154 1.2×	64 0.8×	127 1.7×	28	614
Dilara Akhoundova Switzerland	12	247 0.8×	118 0.8×	113 0.9×	37 0.5×	148 1.9×	45	425
Aiwen Wu China	11	283 0.9×	124 0.8×	83 0.6×	99 1.3×	98 1.3×	29	429
Marco Imperatori Italy	10	273 0.9×	121 0.8×	106 0.8×	29 0.4×	111 1.5×	13	424
Deirdre Kelly Canada	10	165 0.5×	83 0.6×	107 0.8×	89 1.1×	87 1.1×	30	362

Countries citing papers authored by Mengdie Yuan

Since Specialization

Citations

This map shows the geographic impact of Mengdie Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdie Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdie Yuan more than expected).

Fields of papers citing papers by Mengdie Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengdie Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdie Yuan. The network helps show where Mengdie Yuan may publish in the future.

Co-authorship network of co-authors of Mengdie Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Mengdie Yuan. A scholar is included among the top collaborators of Mengdie Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengdie Yuan. Mengdie Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Casak, Sandra J., Vaibhav Kumar, Chi Song, et al.. (2024). FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer. Clinical Cancer Research. 30(16). 3371–3377. 7 indexed citations

Casak, Sandra J., M. Naomi Horiba, Mengdie Yuan, et al.. (2023). FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2 -Positive RAS Wild-Type Colorectal Cancer. Clinical Cancer Research. 29(21). 4326–4330. 21 indexed citations

Saung, May Tun, Lorraine Pelosof, Sandra J. Casak, et al.. (2021). FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib. The Oncologist. 26(9). 797–806. 77 indexed citations

Marcus, Leigh, Lola A. Fashoyin‐Aje, Martha Donoghue, et al.. (2021). FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors. Clinical Cancer Research. 27(17). 4685–4689. 330 indexed citations breakdown →

Zheng, Jiayin, et al.. (2019). Simultaneous confidence interval methods for analytical similarity assessment. Journal of Biopharmaceutical Statistics. 29(5). 920–940. 4 indexed citations

Yuan, Mengdie & Guoqing Diao. (2017). Sieve maximum likelihood estimation in generalized linear models with an unknown link function. Wiley Interdisciplinary Reviews Computational Statistics. 10(2). 6 indexed citations

Zheng, Jiayin, Shein‐Chung Chow, & Mengdie Yuan. (2017). On assessing bioequivalence and interchangeability between generics based on indirect comparisons. Statistics in Medicine. 36(19). 2978–2993. 2 indexed citations

Yuan, Mengdie & Guoqing Diao. (2014). Semiparametric Odds Rate Model for Modeling Short-Term and Long-Term Effects with Application to a Breast Cancer Genetic Study. The International Journal of Biostatistics. 10(2). 231–249. 3 indexed citations

Tsong, Yi, et al.. (2013). Comparing the Response Rates for Superiority, Noninferiority and Equivalence Testing with Multiple-to-One Matched Binary Data. Journal of Biopharmaceutical Statistics. 23(1). 98–109. 1 indexed citations

10.

Yuan, Mengdie & Guoqing Diao. (2011). Joint association analysis of bivariate quantitative and qualitative traits. BMC Proceedings. 5(S9). S74–S74. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact